WO2003092714A3 - Peptide variants of ige constrained by beta-lactam bond - Google Patents
Peptide variants of ige constrained by beta-lactam bond Download PDFInfo
- Publication number
- WO2003092714A3 WO2003092714A3 PCT/EP2003/004551 EP0304551W WO03092714A3 WO 2003092714 A3 WO2003092714 A3 WO 2003092714A3 EP 0304551 W EP0304551 W EP 0304551W WO 03092714 A3 WO03092714 A3 WO 03092714A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ige
- constrained
- beta
- present
- lactam bond
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 5
- 238000009169 immunotherapy Methods 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003229761A AU2003229761A1 (en) | 2002-04-30 | 2003-04-28 | Peptide variants of ige constrained by beta-lactam bond |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0209878.8A GB0209878D0 (en) | 2002-04-30 | 2002-04-30 | Vaccine |
GB0209878.8 | 2002-04-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003092714A2 WO2003092714A2 (en) | 2003-11-13 |
WO2003092714A3 true WO2003092714A3 (en) | 2004-03-18 |
Family
ID=9935802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/004551 WO2003092714A2 (en) | 2002-04-30 | 2003-04-28 | Peptide variants of ige constrained by beta-lactam bond |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003229761A1 (en) |
GB (1) | GB0209878D0 (en) |
WO (1) | WO2003092714A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2552999A1 (en) * | 2004-02-02 | 2005-08-18 | Tanox, Inc. | Identification of novel ige epitopes |
KR101644221B1 (en) | 2008-12-09 | 2016-07-29 | 화이자 백신스 엘엘씨 | IgE CH3 PEPTIDE VACCINE |
RU2518291C2 (en) | 2009-07-30 | 2014-06-10 | Пфайзер Вэксинс ЭлЭлСи | Antigen tau-peptides and their application |
KR101660577B1 (en) | 2009-09-03 | 2016-09-27 | 화이자 백신스 엘엘씨 | Pcsk9 vaccine |
EP2575868A1 (en) | 2010-06-07 | 2013-04-10 | Pfizer Vaccines LLC | Ige ch3 peptide vaccine |
US20140004142A1 (en) | 2011-03-02 | 2014-01-02 | Pfizer Inc. | Pcsk9 vaccine |
US10279019B2 (en) | 2014-02-11 | 2019-05-07 | Stc.Unm | PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same |
US12121574B2 (en) | 2021-09-28 | 2024-10-22 | Unm Rainforest Innovations | Malaria immunogen and methods for using same |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0269455A2 (en) * | 1986-11-28 | 1988-06-01 | Takeda Chemical Industries, Ltd. | Highly purified fused protein comprising human IgE Fc fragment and production thereof |
WO2000050460A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
WO2000050461A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses |
WO2002016409A2 (en) * | 2000-08-22 | 2002-02-28 | Glaxosmithkline Biologicals S.A. | Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
WO2002034288A2 (en) * | 2000-10-27 | 2002-05-02 | Smithkline Beecham Biologicals S.A. | Vaccine for treating allergy |
EP1262491A2 (en) * | 2001-05-22 | 2002-12-04 | Pfizer Products Inc. | Non-anaphylactogenic IgE vaccines |
US6500660B1 (en) * | 1996-11-27 | 2002-12-31 | Université Catholique de Louvain | Chimeric target molecules having a regulatable activity |
-
2002
- 2002-04-30 GB GBGB0209878.8A patent/GB0209878D0/en not_active Ceased
-
2003
- 2003-04-28 WO PCT/EP2003/004551 patent/WO2003092714A2/en not_active Application Discontinuation
- 2003-04-28 AU AU2003229761A patent/AU2003229761A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0269455A2 (en) * | 1986-11-28 | 1988-06-01 | Takeda Chemical Industries, Ltd. | Highly purified fused protein comprising human IgE Fc fragment and production thereof |
US6500660B1 (en) * | 1996-11-27 | 2002-12-31 | Université Catholique de Louvain | Chimeric target molecules having a regulatable activity |
WO2000050460A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
WO2000050461A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses |
WO2002016409A2 (en) * | 2000-08-22 | 2002-02-28 | Glaxosmithkline Biologicals S.A. | Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
WO2002034288A2 (en) * | 2000-10-27 | 2002-05-02 | Smithkline Beecham Biologicals S.A. | Vaccine for treating allergy |
EP1262491A2 (en) * | 2001-05-22 | 2002-12-04 | Pfizer Products Inc. | Non-anaphylactogenic IgE vaccines |
Non-Patent Citations (2)
Title |
---|
ASERO RICCARDO ET AL: "Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors.", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. SWITZERLAND JUL 2003, vol. 131, no. 3, July 2003 (2003-07-01), pages 195 - 200, XP002264568, ISSN: 1018-2438 * |
LEGENDRE D ET AL: "Engineering a regulatable enzyme for homogeneous immunoassays.", NATURE BIOTECHNOLOGY. UNITED STATES JAN 1999, vol. 17, no. 1, January 1999 (1999-01-01), pages 67 - 72, XP002264567, ISSN: 1087-0156 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003092714A2 (en) | 2003-11-13 |
AU2003229761A1 (en) | 2003-11-17 |
AU2003229761A8 (en) | 2003-11-17 |
GB0209878D0 (en) | 2002-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01008612A (en) | Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses. | |
UA90457C2 (en) | Human monoclonal antibody that specifically binds to human m-csf | |
WO2005019258A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004018649A3 (en) | Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein | |
WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2002043661A3 (en) | Recombinant anti-cd30 antibodies and uses thereof | |
WO2003092624A3 (en) | Use of heat shock proteins to enhance efficacy of antibody therapeutics | |
EP2213684A3 (en) | Nogo-a antibodies for the treatment of Alzheimer disease | |
WO2007044756A3 (en) | Monoclonal antibodies recognizing human ccr8 | |
WO2004103306A3 (en) | Immunosuppressant compounds and compositions | |
WO2004103309A3 (en) | Immunosuppressant compounds and compositions | |
WO2004113330A8 (en) | Immunosuppressant compounds and compositions | |
WO2007033230A3 (en) | Anti-cd3 antibody formulations | |
WO2001001748A3 (en) | Peptide compounds that bind her2 | |
WO2004094473A3 (en) | Humanized antibodies to interferon alpha receptor-1 (ifnar-1) | |
WO2003075846A3 (en) | Uses of monoclonal antibody 8h9 | |
WO2003092714A3 (en) | Peptide variants of ige constrained by beta-lactam bond | |
WO2005120558A3 (en) | Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease | |
WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
WO2005080428A3 (en) | Anti-epcam immunoglobulins | |
MXPA01008613A (en) | Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses. | |
WO2002034288A8 (en) | Vaccine for treating allergy | |
WO2004083382A3 (en) | Compositions and methods for treating hyperimmune response in the eye | |
WO2006137938A3 (en) | Antibody fragments for protection from pathogen infection and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |